Literature DB >> 20006387

HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia.

Jing-Shan Wu1, Ian James, Wei Qiu, Alison Castley, Frank T Christiansen, William M Carroll, Frank L Mastaglia, Allan G Kermode.   

Abstract

Susceptibility to multiple sclerosis (MS) has been consistently associated with the Human Leukocyte Antigen (HLA)-DRB11501 genotype, however effects on disease severity and clinical outcome have varied in different populations. We present the results of a high-resolution HLA-DRB1 genotyping and genotype-phenotype correlation study in a large West Australian MS cohort. Our findings indicate that in this population, which is of largely Anglo-Celtic and Northern European origin, HLA-DRB11501 is not only a strong determinant of disease risk but may also be associated with disease severity as measured by the Multiple Sclerosis Severity Score (MSSS), with the MSSS increasing by an estimated 0.51 per DRB11501 allele. We also found evidence that the HLA-DRB11201 allele is associated with less severe disease. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20006387     DOI: 10.1016/j.jneuroim.2009.11.015

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

Review 1.  Multiple sclerosis genetics--is the glass half full, or half empty?

Authors:  Jorge R Oksenberg; Sergio E Baranzini
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

2.  Deconstruction of HLA-DRB1*04:01:01 and HLA-DRB1*15:01:01 class II haplotypes using next-generation sequencing in European-Americans with multiple sclerosis.

Authors:  Lisa E Creary; Kalyan C Mallempati; Sridevi Gangavarapu; Stacy J Caillier; Jorge R Oksenberg; Marcelo A Fernández-Viňa
Journal:  Mult Scler       Date:  2018-04-23       Impact factor: 6.312

3.  T cell epitope mapping of JC polyoma virus-encoded proteome reveals reduced T cell responses in HLA-DRB1*04:01+ donors.

Authors:  Ilijas Jelcic; Lilian Aly; Thomas M C Binder; Ivan Jelcic; Sílvia Bofill-Mas; Raquel Planas; Victoria Demina; Thomas H Eiermann; Thomas Weber; Rosina Girones; Mireia Sospedra; Roland Martin
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

4.  HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data.

Authors:  Mitsuru Watanabe; Yuri Nakamura; Shinya Sato; Masaaki Niino; Hikoaki Fukaura; Masami Tanaka; Hirofumi Ochi; Takashi Kanda; Yukio Takeshita; Takanori Yokota; Yoichiro Nishida; Makoto Matsui; Shigemi Nagayama; Susumu Kusunoki; Katsuichi Miyamoto; Masanori Mizuno; Izumi Kawachi; Etsuji Saji; Takashi Ohashi; Shun Shimohama; Shin Hisahara; Kazutoshi Nishiyama; Takahiro Iizuka; Yuji Nakatsuji; Tatsusada Okuno; Kazuhide Ochi; Akio Suzumura; Ken Yamamoto; Yuji Kawano; Shoji Tsuji; Makoto Hirata; Ryuichi Sakate; Tomonori Kimura; Yuko Shimizu; Akiko Nagaishi; Kazumasa Okada; Fumie Hayashi; Ayako Sakoda; Katsuhisa Masaki; Koji Shinoda; Noriko Isobe; Takuya Matsushita; Jun-Ichi Kira
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.